QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
OTCMKTS:ERFSF

Eurofins Scientific - ERFSF Price Target & Analyst Ratings

$65.89
+0.12 (+0.18%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$65.89
▼
$66.42
50-Day Range
$62.86
▼
$75.13
52-Week Range
$54.75
▼
$108.50
Volume
153 shs
Average Volume
1,565 shs
Market Capitalization
$12.68 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$67.50

Eurofins Scientific Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 5 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
3/27/22 to 3/27/23		1 Month Ago
2/25/22 to 2/25/23		3 Months Ago
12/27/21 to 12/27/22		1 Year Ago
3/27/21 to 3/27/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Predicted UpsideN/AN/AN/AN/A
Get Eurofins Scientific Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ERFSF and its competitors with MarketBeat's FREE daily newsletter.

ERFSF Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ERFSF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Eurofins Scientific Stock vs. The Competition

TypeEurofins ScientificMedical CompaniesS&P 500
Consensus Rating Score
1.60
2.64
2.47
Consensus RatingHoldBuyHold
Predicted Upside1,991.42% Upside22.48% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/11/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeHold ➝ Sell
1/11/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeHold ➝ Underperform
10/20/2022Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Delphine Le Louet
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetHold ➝ Hold€73.30 ➝ €65.00
7/8/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Edward Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetEqual Weight ➝ Equal Weight€95.00 ➝ €70.00
4/8/2022HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeReduce ➝ Hold
2/24/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Andy Grobler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOutperform ➝ Outperform€125.00 ➝ €110.00
2/24/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target€125.00 ➝ €105.00
2/24/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy
2/3/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Buy
8/25/2021Bryan, Garnier & Co
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Bruno De
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeStrong-Buy ➝ Neutral
(Data available from 3/27/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ERFSF Price Target - Frequently Asked Questions

What is Eurofins Scientific's consensus rating?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Eurofins Scientific stock is Hold based on the current 2 sell ratings and 3 hold ratings for ERFSFthe . Learn more on ERFSF's analyst rating history.

Do Wall Street analysts like Eurofins Scientific more than its competitors?

Analysts like Eurofins Scientific less than other Medical companies. The consensus rating for Eurofins Scientific is Hold while the average consensus rating for medical companies is Buy. Learn more on how ERFSF compares to other companies.

Is Eurofins Scientific being downgraded by Wall Street analysts?

Over the previous 90 days, Eurofins Scientific's stock had 2 downgrades by analysts.

What analysts cover Eurofins Scientific?

Eurofins Scientific has been rated by Deutsche Bank Aktiengesellschaft, and Jefferies Financial Group in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (OTCMKTS:ERFSF) was last updated on 3/27/2023 by MarketBeat.com Staff